Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors

J Am Coll Cardiol. 2015 Dec 1;66(21):2282-2284. doi: 10.1016/j.jacc.2015.07.086.

Authors

Gregory Y H Lip¹, Deirdre A Lane²

Affiliations

¹ University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: g.y.h.lip@bham.ac.uk.
² University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom.

PMID: 26610875
DOI: 10.1016/j.jacc.2015.07.086

No abstract available

Keywords: NOACs; atrial fibrillation; gastrointestinal bleeding; oral anticoagulation.

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / adverse effects*
Atrial Fibrillation / drug therapy*
Female
Gastrointestinal Hemorrhage / chemically induced*
Gastrointestinal Hemorrhage / diagnosis*
Humans
Male
Rivaroxaban / adverse effects*
Warfarin / adverse effects*

Substances

Anticoagulants
Warfarin
Rivaroxaban